Gecina Shares Bounce Back 5% in a Week Despite Berenberg Downgrade

Berenberg Revises Price Target for Gecina

The day before, the analysis firm Berenberg revised its price target on Gecina, reducing it from 110 to 95 euros, while maintaining its buy recommendation. At the current price of 72.35 euros, this target implies a potential revaluation of about 31%. The adjustment of the target reflects a significant recalibration, with the discount now reaching nearly 15 euros compared to the previous valuation held by the German analyst. This movement is part of a context of a marked decline in the stock over one year: the twelve-month performance is at -16.26%, and the three-month drop is -8.42%. The 200-day moving average, established at 80.47 euros, indicates a persistent distancing of the price from its long-term trend. The next appointment for shareholders will be the general meeting on April 22, followed by the publication of the first semester results on July 22.

Technical Analysis of Gecina's Recent Rebound

Technically, last week's rebound has propelled Gecina's stock price into the upper part of its Bollinger Bands: at 72.35 euros, it is at 96% of the range formed by the lower boundary (64.69 euros) and the upper boundary (72.70 euros), a zone associated with potential overbuying. The RSI, at 56, does not yet indicate directional excess but confirms a moderate buying momentum. The CAC 40 is down 0.52% in the session, at 8,284 points, while the SBF 120 falls by 0.47%. Across the Atlantic, the S&P 500 is up 1.18% in session. Among the listed real estate companies in the United States, Prologis is up by 0.88% and Simon Property Group by 1.12%, while American Tower drops 2.50%. Gecina's nearly zero beta (-0.04) highlights the low correlation of the stock with general market movements, a common characteristic of regulated real estate values.